Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan

被引：0
作者：
Taku Aoki
Norihiro Kokudo
Izumi Komoto
Kyoichi Takaori
Wataru Kimura
Keiji Sano
Takeshi Takamoto
Takuya Hashimoto
Takuji Okusaka
Chigusa Morizane
Tetsuhide Ito
Masayuki Imamura
机构：
[1] The University of Tokyo,Hepato
[2] The University of Tokyo,Biliary
[3] Kansai Electric Power Company Hospital,Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine
[4] Kyoto University,Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine
[5] Yamagata University Faculty of Medicine,Department of Surgery
[6] Teikyo University School of Medicine,Department of Hepatobiliary
[7] Japanese Red Cross Medical Center,Pancreatic Surgery and Transplantation, Graduate School of Medicine
[8] National Cancer Center Hospital,Department of Gastroenterological, Breast, Thyroid, and General Surgery
[9] Kyushu University,Department of Surgery
来源：
Journal of Gastroenterology | 2015年 / 50卷
关键词：
Neuroendocrine tumors; Streptozocin; Multi-center survey; Tumor response; Progression-free survival rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 775
页数：6
相关论文
共 36 条
  • [31] Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database
    Assi, Hussein A.
    Mukherjee, Sarbajit
    Kunz, Pamela L.
    Machiorlatti, Michael
    Vesely, Sara
    Pareek, Vipul
    Hatoum, Hassan
    [J]. ONCOLOGIST, 2020, 25 (02) : E276 - E283
  • [32] Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
    Diamantopoulos, Leonidas N.
    Kalligeros, Markos
    Halfdanarson, Thorvardur R.
    Diamantis, Nikolaos
    Toumpanakis, Christos
    [J]. BIOLOGY-BASEL, 2023, 12 (08):
  • [33] Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
    Krug, Sebastian
    Kegel, Thomas
    Gress, Thomas M.
    Rinke, Anja
    Apostolidis, Leonidas
    Jann, Henning
    Koenig, Alexander
    Hoersch, Dieter
    Schrader, Joerg
    Ettrich, Thomas J.
    Richter, Michael
    Steighardt, Joerg
    Michl, Patrick
    [J]. BMC CANCER, 2021, 21 (01)
  • [34] A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
    Reidy-Lagunes, Diane L.
    Vakiani, Efsevia
    Segal, Michal F.
    Hollywood, Ellen M.
    Tang, Laura H.
    Solit, David B.
    Pietanza, M. Catherine
    Capanu, Marinela
    Saltz, Leonard B.
    [J]. CANCER, 2012, 118 (19) : 4795 - 4800
  • [35] Evaluation of immunohistochemical expression of novel neuroendocrine marker INSM1 and histological tumor growth pattern in well-differentiated neuroendocrine tumors of the appendix: 15-year single tertiary center experience
    Koyuncuer, Ali
    Canbak, Tolga
    Acar, Aylin
    Sahin, Onur
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2024, 67 (02) : 282 - 288
  • [36] Evaluation of survival outcomes in patients with sporadic, advanced, unresectable well-differentiated pancreatic neuroendocrine tumors treated initially with octreotide LAR and subsequent therapeutical approaches on relapse. A real-world data set
    Kolasinska-Cwikla, Agnieszka
    Gutowska, Klaudia
    Osowiecka, Karolina
    Bednarczuk, Tomasz
    Sloniewska, Anna
    Roszkowska-Purska, Katarzyna
    Palucki, Jakub
    Cwikla, Jaroslaw B.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (05): : 290 - 301
1234